“…While AQP5 knock-out mice have no discernable difference in baseline phenotype, changes in AQP5 have been implicated in the pathogenesis of acute lung injury, as well as in the development of xerostomia, lung submucosal glandular secretions, and in the regulation of sweat ( Song and Verkman, 2001 ; Verkman, 2007 ; Inoue, 2016 ; Zhang J. et al, 2018 ; Hosoi et al, 2020 ). Additionally, AQP5 expression is regulated by a number of transcriptional and post-translational mechanisms, including inflammatory signals ( Towne et al, 2000 ; Towne et al, 2001 ; Hasan et al, 2014 ; Vassiliou et al, 2017 ), cAMP ( Yang et al, 2003 ), hypoxia, ( Kawedia et al, 2013 ), shear stress ( Sidhaye et al, 2008 ), and tonicity ( Sidhaye et al, 2006 ). Here we use a novel high-throughput screening approach based on AQP5 abundance to identify repurposed drugs that increased AQP5.…”